Clinical Trial Update: Comparative Bioavailability in Healthy Elderly Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting the comparative bioavailability of TauRx's Alzheimer’s disease drug in healthy elderly volunteers. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LMTX (methylthioninium chloride)

Snippet

Sponsor: TauRx Therapeutics Ltd | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED